DoMo Genetics for Oncology
HOW DOES IT WORK?
WE REDUCE TEST TIME FROM 3 DAYS TO ONLY 2 HOURS
Easy to use
YOU DON’T CHANGE YOUR PROTOCOL, YOU SIMPLY ADD WITH THE PROBE
WE REDUCE THE COSTS UP TO 50%
SEE OUR PROTOCOLS FOR FFPE TISSUES: FAST AND UNIVERSAL FISH
Among the many miseries diseases bring, the anguish of waiting for a diagnosis is one of the worst.
We mitigate some of this anguish by majorly reducing the time for diagnostic tests.
Our objective is to provide diagnostics laboratories and research institutions
with solutions that will disrupt diagnosis times and cost.
Il continuo monitoraggio del virus SARS-CoV-2 e delle sue varianti, tramite unica PCR, è lo strumento più efficace nelle mani dei sistemi sanitari mondiali per mantenere sotto controllo il virus responsabile della CoViD-19 ed intercettare sul nascere nuovi focolai. ...
Omicron or B.1.1.529, the last “version” of SARS-CoV-2 original strain, was identified almost two months ago. Today, Omicron is going to replace Delta variant prevalence in almost all countries. According to ECDC monitor of Gisaid data, at the moment we write,...
SGTF versus N501Y mutation detection in the diagnosis of the Omicron variant’s two clades: BA.1 and BA.2
Omicron tracked in 77 countries The latest WHO weekly report, dated 12/13/2021 reveals that the number of people affected by Omicron is increasing sharply worldwide. Omicron variant is characterised by more than 30 mutations in Spike region and has been split into two...
Individuata una nuova forma di Omicron invisibile ad alcuni KIT PCR: l’OMS sta valutando la separazione in BA.1 e BA.2
Nuova forma di variante Omicron Una nuova versione della variante Omicron (B.1.1.529) è stata recentemente messa sotto i riflettori dal gruppo Pango-designation, dopo che in pochissimi giorni decine di nuove rilevazioni sono state depositate nel database Gisaid,...
OaCP has reached the 2nd place in the 5th China (Shenzhen) Innovation & Entrepreneurship International Competition
OaCP has been awarded with the 2nd prize of the 5th China (Shenzhen) Innovation & Entrepreneurship International Competition. The "Fly With Shenzhen" competition aims at integrating innovation and entrepreneurship resources, assisting overseas innovation and...
OaCP in the top 5 Big Health companies of the China Overseas Talent Innovation and Entrepreneurship Competition
OaCP has won the 4th prize within the Big Health area of expertise of the China Overseas Talent Innovation and Entrepreneurship Competition promoted by Wuhan City. The competition is hosted by China Association for Science and Technology (CAST), People's Government of...
RT- PCR, the gold standard in CoViD-19 diagnosis: the most common pitfalls and their interpretations
The gold standard for SARS-CoV-2 diagnosis is the Reverse Transcriptase Polymerase Chain Reaction, aka RT-PCR or qRT-PCR. This technique has been introduced in 1983 (Saiki et al. 1985) and nowadays is widely used in the diagnosis of many pathologies, from infectious...
The Judging Panel of the Go Global Awards has announced that OACP IE LTD has made the short-list for the Go Global Awards as Start-Up Exporter of the Year. Learn more on https://www.zghcl.net/chuangye/index-e.html THE GO GLOBAL AWARDS The International Trade Council’s...
Intervista rilasciata dal nostro CEO Enrico Di Oto a Marco Bettazzi per la Repubblica Bologna, sezione Economia - 30 agosto 2021 Tra febbraio e marzo hanno sviluppato il primo tampone rapido al mondo per individuare le varianti del Covid, in collaborazione con una...
As the media have been writing for weeks, the DELTA variant (born as variant B.1.617.2), first identified in mid-2020, is spreading fast. According to last ECDC commentary, the highly infectious variant of concern (V.O.C.) DELTA is becoming “dominant in much of the...